Safety and efficacy of Melissa officinalis (lemon balm) on ApoA-I, Apo B, lipid ratio and ICAM-1 in type 2 diabetes patients: A randomized, double-blinded clinical trial.
CONCLUSIONS: M. officinalis is safe and effective in improvement of Apo A-I, Apo B/Apo A-I, and lipids ratios as key factors promoting cardiovascular disease (CVD) in type II diabetic patients.
PMID: 30219475 [PubMed - in process]
Source: Complementary Therapies in Medicine - Category: Complementary Medicine Authors: Asadi A, Shidfar F, Safari M, Malek M, Hosseini AF, Rezazadeh S, Rajab A, Shidfar S, Hosseini S Tags: Complement Ther Med Source Type: research
More News: Alternative and Complementary Therapies | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Lemon Balm | Liver | Study | Urology & Nephrology